Sphingosine 1-phosphate derived from tumor-educated hepatic stellate cells combining with S1PR4 promotes tumor

Rui Feng1, Zilin Cui2, Long Yang1

  • 1Department of Hepatobiliary Surgery, Tianjin First Central Hospital, Tianjin, 300192, China.

Scientific Reports
|July 1, 2025
PubMed

Insights

Tumor cells activate hepatic stellate cells to produce S1P, which drives M2 macrophage differentiation. This lipid metabolite signaling pathway promotes tumor growth by reprogramming the tumor immune microenvironment.

Area of Science:

  • Immunology
  • Cancer Biology
  • Metabolic Pathways

Background:

  • The tumor immune microenvironment (TIME) significantly influences cancer progression.
  • Macrophages differentiate into tumor-associated macrophages (TAMs) within the tumor microenvironment (TME), altering their metabolic functions.
  • Sphingosine-1-phosphate (S1P) is a lipid metabolite involved in immune regulation, but its role in TAM differentiation and metabolism, and its source in the TME, remain unclear.

Purpose of the Study:

  • To investigate the role of S1P in TAM differentiation and metabolic regulation.
  • To identify the source of S1P within the TME.
  • To elucidate the signaling pathway connecting tumor cells, hepatic stellate cells (HSCs), and macrophages.

Main Methods:

  • Co-culture of hepatic stellate cells with tumor cells to observe macrophage differentiation.
  • Analysis of S1P receptor 4 (S1PR4) and peroxisome proliferator-activated receptor α (PPARα) activation in macrophages.
  • Investigation of the nuclear factor erythroid 2-related factor 2 (Nrf2) and sphingosine kinase 1 (SphK1) pathway in HSCs.

Main Results:

  • Co-culture of HSCs and tumor cells induced macrophage differentiation into M2-type TAMs.
  • S1P activated PPARα via S1PR4 on macrophages, upregulating lipid metabolism and promoting M2 TAM differentiation.
  • Tumor cells activated the Nrf2/SphK1 pathway in HSCs, increasing S1P production and secretion.

Conclusions:

  • Tumor cells orchestrate a signaling cascade involving HSCs and macrophages to promote a pro-tumorigenic TIME.
  • The Nrf2/SphK1 pathway in HSCs, stimulated by tumor cells, leads to S1P secretion.
  • S1P acts on macrophages, activating S1PR4/PPARα, driving M2 TAM polarization and supporting tumor progression.